Page last updated: 2024-12-11

trilinolenin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

trilinolenin: RN refers to (cis,cis,cis)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,2,3-trilinolenoylglycerol : A triglyceride formed by acylation of the three hydroxy groups of glycerol with linolenic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5462874
CHEBI ID75845
SCHEMBL ID114353
MeSH IDM0265643

Synonyms (50)

Synonym
1,2,3-tri-(9z,12z,15z-octadecatrienoyl)-glycerol
tg(18:3/18:3/18:3)
LMGL03010527
tg(18:3(9z,12z,15z)/18:3(9z,12z,15z)/18:3(9z,12z,15z))
trilinolenin
glyceryl trilinolenate, >=97% (tlc), liquid
trilinolenin c18:3
propane-1,2,3-triyl (9z,12z,15z,9'z,12'z,15'z,9''z,12''z,15''z)tris-octadeca-9,12,15-trienoate
14465-68-0
2,3-bis[[(9z,12z,15z)-octadeca-9,12,15-trienoyl]oxy]propyl (9z,12z,15z)-octadeca-9,12,15-trienoate
1,2,3-propanetriyl-9,12,15-octadecatrienoate
9,12,15-octadecatrienoic acid, 1,2,3-propanetriyl ester
1,2,3-propanetriyl linolenate
glyceryl trilinolenate
unii-oi7s0a9873
linolenic acid, 1,2,3-propanetriyl ester
einecs 238-457-5
glycerol trilinolenate
propane-1,2,3-triyl tris((9z,12z,15z)-octadeca-9,12,15-trienoate)
oi7s0a9873 ,
1,2,3-trilinolenoylglycerol
tg[18:3(omega-3)/18:3(omega-3)/18:3(omega-3)]
triacylglycerol(18:3/18:3/18:3)
triacylglycerol(54:9)
1,2,3-tri-(9z,12z,15z-octadecatrienoyl)glycerol
CHEBI:75845
1,2,3-tri-(9z,12z,15z)-octadecatrienoylglycerol
tag(54:9)
linolenoyl triglyceride
tag(18:3/18:3/18:3)
linolenin, tri-
vitamin f [who-dd]
vitamin f glycerinester
9,12,15-octadecatrienoic acid, 1,1',1''-(1,2,3-propanetriyl) ester, (9z,9'z,9''z,12z,12'z,12''z,15z,15'z,15''z)-
9,12,15-octadecatrienoic acid, 1,2,3-propanetriyl ester, (all-z)-
tri-.alpha.-linolenin
9,12,15-octadecatrienoic acid, 1,2,3-propanetriyl ester, (9z,9'z,9''z,12z,12'z,12''z,15z,15'z,15''z)-
trilinolenin [inci]
SCHEMBL114353
DTXSID6042654
UBEIMDKGOYBUKT-FLIQGJDUSA-N
J-007993
1-a-linolenoyl-2-a-linolenoyl-3-a-linolenoyl-glycerol
1-(9z,12z,15z-octadeatrienoyl)-2-(9z,12z,15z-octadeatrienoyl)-3-(9z,12z,15z-octadeatrienoyl)-glycerol
Q27145591
tri-9(z),12(z),15(z)-octadecatrienoin, trilinolenin
tri-9(z),12(z),15(z)-octadecatrienoin
1, 2, 3-trilinolenoylglycerol
PD044130
tg 18:3_18:3_18:3

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Trilinolenin (18:3; omega-3) was toxic only after prolonged incubation."( Toxicity of polyunsaturated fatty acid esters for human monocyte-macrophages: the anomalous behaviour of cholesteryl linolenate.
Carpenter, KL; Hardwick, SJ; Hird, R; Law, NS; Marchant, CE; Mitchinson, MJ; Van Der Veen, C, 1997
)
1.21

Bioavailability

ExcerptReferenceRelevance
" In a 2-week-long term, daily gavage study, the bioavailability of fish oil and fish oil in Cas-Glu-DGS-50 or Cas-Hylon-25 demonstrated that fish oil and Cas-Glu-DGS-50 LC n-3 PUFA were incorporated into the tissue of the small intestine and colon, whereas Cas-Hylon-25 was resistant to degradation in the small intestine."( Site specific delivery of microencapsulated fish oil to the gastrointestinal tract of the rat.
Abeywardena, MY; Augustin, MA; Head, RJ; Patten, GS; Sanguansri, L, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triacylglycerol 54:9
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Triacylglycerol Degradation TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))511
De Novo Triacylglycerol Biosynthesis TG(18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z))513

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's3 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.22 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.99 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]